BOSTON SCIENTIFIC CORPORATION Boston Scientific Corporation Stock
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.49 USD | +0.93% |
|
+0.08% | +27.12% |
| May. 13 | Boston Scientific Insider Sold Shares Worth $958,717, According to a Recent SEC Filing | MT |
| May. 08 | Boston Scientific Insider Sold Shares Worth $286,874, According to a Recent SEC Filing | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2024 * | 15.98B | Sales 2025 * | 17.55B | Capitalization | 108B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.19B | Net income 2025 * | 2.72B | EV / Sales 2024 * | 7.14 x |
| Net Debt 2024 * | 6.06B | Net Debt 2025 * | 3.7B | EV / Sales 2025 * | 6.37 x |
| P/E ratio 2024 * |
50.1
x | P/E ratio 2025 * |
40.7
x | Employees | 48,000 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.65% |
More Fundamentals
* Assessed data
More news
Latest transcript on Boston Scientific Corporation
More recommendations
More press releases
More news
| 1 day | +0.93% | ||
| 1 week | +0.08% | ||
| Current month | +2.25% | ||
| 1 month | +7.96% | ||
| 3 months | +11.43% | ||
| 6 months | +36.04% | ||
| Current year | +27.12% |
1 week
72.31
74.30
1 month
66.8074.39
Current year
57.1174.39
1 year
48.3574.39
3 years
34.9874.39
5 years
24.1074.39
10 years
11.1074.39
| Managers | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 59 | 11-10-16 |
Daniel Brennan
DFI | Director of Finance/CFO | 58 | 96-11-30 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 09-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 71 | 16-07-12 | |
David Wichmann
BRD | Director/Board Member | 61 | 21-06-22 |
| Director/Board Member | 69 | 15-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.26% | 12 M€ | +15.09% | - | |
| 1.98% | 1 M€ | +2.21% | - | |
| 1.75% | 17 M€ | +7.01% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-14 | 73.49 | +0.93% | 5,848,511 |
| 24-05-13 | 72.81 | -1.19% | 6,182,025 |
| 24-05-10 | 73.69 | -0.55% | 3,790,579 |
| 24-05-09 | 74.1 | +1.90% | 6,134,777 |
| 24-05-08 | 72.72 | -0.97% | 5,054,088 |
Delayed Quote Nyse, May 14, 2024 at 04:00 pm EDT
More quotes
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Calendar
2024-05-29
- Bernstein Strategic Decisions Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
73.49
USD
Average target price
81.16
USD
Spread / Average Target
+10.44%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +27.12% | 108B | |
| +12.06% | 227B | |
| +12.07% | 192B | |
| +13.88% | 136B | |
| +0.91% | 64.07B | |
| +6.74% | 51.87B | |
| +13.39% | 52.1B | |
| +8.81% | 44.33B | |
| +4.14% | 36.75B | |
| +25.48% | 31.71B |
- Stock Market
- Equities
- BSX Stock